Open access · CC-BY
via OpenAlex
Mesenchymal stem cell therapy for osteoarthritis: current perspectives
Cody C. Wyles, Matthew T. Houdek, Atta Behfar, Rafael J. Sierra
Stem Cells and Cloning Advances and Applications · 2015 · ▲ 106 citations
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Partial reprogramming (OSK)
Human
Review
Abstract
Osteoarthritis (OA) is a painful chronic condition with a significant impact on quality of life. The societal burden imposed by OA is increasing in parallel with the aging population; however, no therapies have demonstrated efficacy in preventing the progression of this degenerative joint disease. Current mainstays of therapy include activity modification, conservative pain management strategies, weight loss, and if necessary, replacement of the affected joint. Mesenchymal stem cells (MSCs) are a multipotent endogenous population of progenitors capable of differentiation to musculoskeletal tissues. MSCs have a well-documented immunomodulatory role, managing the inflammatory response primarily through paracrine signaling. Given these properties, MSCs have been proposed as a potential regenerative cell therapy source for patients with OA. Research efforts are focused on determining the ideal source for derivation, as MSCs are native to several tissues. Furthermore, optimizing the mode of delivery remains a challenge both for appropriate localization of MSCs and for directed guidance toward stemming the local inflammatory process and initiating a regenerative response. Scaffolds and matrices with growth factor adjuvants may prove critical in this effort. The purpose of this review is to summarize the current state of MSC-based therapeutics for OA and discuss potential barriers that must be overcome for successful implementation of cell-based therapy as a routine treatment strategy in orthopedics.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/sccaa.s68073
- Canonical
- link ↗
- Fetched
- 2026-09-13 MST
Cite this
APA
Wyles, C.C., Houdek, M.T., Behfar, A., & Sierra, R.J. (2015). Mesenchymal stem cell therapy for osteoarthritis: current perspectives. <em>Stem Cells and Cloning Advances and Applications</em>. https://doi.org/10.2147/sccaa.s68073
Vancouver
Wyles CC, Houdek MT, Behfar A, Sierra RJ. Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells and Cloning Advances and Applications. 2015. doi:10.2147/sccaa.s68073.
BibTeX
@article{cody2015Mesenc,
title = {Mesenchymal stem cell therapy for osteoarthritis: current perspectives},
author = {Cody C. Wyles and Matthew T. Houdek and Atta Behfar and Rafael J. Sierra},
journal = {Stem Cells and Cloning Advances and Applications},
year = {2015},
doi = {10.2147/sccaa.s68073},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
World Journal of Stem Cells 2014
Open access · CC-BY
Mesenchymal stem cells for treatment of aortic aneurysms
Clinical and Translational Medicine 2016
Open access · CC-BY
Therapeutic potential of mesenchymal stem cell based therapy for osteoarthritis
Journal of Personalized Medicine 2021
Open access · CC-BY
Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light
BioMed Research International 2011
Open access · CC-BY
Mesenchymal Stem Cell‐Based Tissue Engineering for Chondrogenesis
Frontiers in Nutrition 2018
Open access · CC-BY